Xiang Zhan
Shijiazhuang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Multi-Omic Analysis of Glioma Identifies RRM2 as a Prognostic Biomarker Associated With Tumor Stemness and Cell Cycle-Related Pathways.
Journal: Technology in cancer research & treatment
Published: May 16, 2026
Construction of a novel risk model for esophageal squamous cell carcinoma associated with purinergic signaling pathways and chemoradiotherapy sensitivity genes.
Journal: Frontiers in medicine
Published: November 14, 2025
Addition of bevacizumab to gefitinib plus chemotherapy as first-line therapy in EGFR L858R mutate advanced non-small cell lung cancer patients.
Journal: Frontiers in pharmacology
Published: September 28, 2024
Osimertinib plus chemotherapy versus osimertinib for patients with advanced NSCLC with concomitant EGFR and TP53 mutations: a prospective cohort study.
Journal: Scientific reports
Published: July 05, 2024
Pyroptosis-related long-noncoding RNA signature predicting survival and immunotherapy efficacy in patients with lung squamous cell carcinoma.
Journal: Clinical and experimental medicine
Published: June 04, 2024
MiR-92a-2-5p suppresses esophageal squamous cell carcinoma cell proliferation and invasion by targeting PRDX2.
Journal: Experimental cell research
Published: August 15, 2023
Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learning.
Journal: Molecular medicine (Cambridge, Mass.)
Published: August 08, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026